HLB Genex, Inc. (KOSDAQ:187420)
2,710.00
-70.00 (-2.52%)
At close: Jan 21, 2026
HLB Genex Revenue
HLB Genex had revenue of 10.18B KRW in the quarter ending September 30, 2025, with 11.32% growth. This brings the company's revenue in the last twelve months to 40.95B, up 17.56% year-over-year. In the year 2024, HLB Genex had annual revenue of 35.43B with 31.18% growth.
Revenue (ttm)
40.95B
Revenue Growth
+17.56%
P/S Ratio
1.89
Revenue / Employee
546.00M
Employees
75
Market Cap
77.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35.43B | 8.42B | 31.18% |
| Dec 31, 2023 | 27.01B | -793.42M | -2.85% |
| Dec 31, 2022 | 27.80B | 1.93B | 7.45% |
| Dec 31, 2021 | 25.87B | 7.10B | 37.85% |
| Dec 31, 2020 | 18.77B | 3.83B | 25.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Creas F&C Co.,Ltd | 484.33B |
| FSN Co., Ltd. | 348.13B |
| APRO Co., Ltd | 209.33B |
| Jeil M&S | 202.36B |
| Icure Pharmaceutical Incorporation | 93.22B |
| M2N Co.,Ltd | 88.99B |
| HRS Co., Ltd | 79.13B |
| WINPAC | 69.62B |